Travaux scientifiques

Prof. Dr. Bekir Uçan

172 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil
  1. Clinical, hormonal, and treatment outcomes in 247 patients with acromegaly: a single tertiary center experience

    Turkish Journal of Medical Sciences, 2026

    DOI 10.55730/1300-0144.6205 PMID 42499429 Texte intégral en libre accèsSource : ORCID

  2. Effect of Intraoperative Nerve Monitorization on Predicting Vocal Cord Paralysis in Thyroid Surgery

    International Archives of Otorhinolaryngology, 2026

    DOI 10.1055/s-0045-1810079 PMID 41821955 Texte intégral en libre accèsSource : ORCID

  3. Clinicopathological predictors of central lymph node metastasis in clinically node-negative papillary thyroid carcinoma: a retrospective cohort analysis

    European Archives of Oto-Rhino-Laryngology, 2026

    DOI 10.1007/s00405-025-09878-9 PMID 41288698 1 citation (Europe PMC) Source : ORCID

  4. Gonadal recovery in men with prolactinomas on cabergoline: 6-month testosterone levels as a predictor of testosterone replacement timing

    Hormones, 2026

    DOI 10.1007/s42000-026-00766-3 PMID 41926073 Source : ORCID

  5. Identification of High-Risk Individuals for Osteoporosis and Fragility Fractures in Cushing's Syndrome: A Promising Predictive Approach

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15062442 PMID 41899363 Texte intégral en libre accèsSource : ORCID

  6. Increased prevalence of abdominal aortic aneurysm in biochemically confirmed primary aldosteronism: a new complication?

    Endocrine, 2026

    DOI 10.1007/s12020-026-04650-3 PMID 42081031 Source : ORCID

  7. Metabolic dysfunction-associated steatotic liver disease in Cushing's syndrome: prevalence, determinants, and changes after remission

    Frontiers in Endocrinology, 2026

    DOI 10.3389/fendo.2026.1790066 PMID 42109743 2 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  8. Reevaluating the Need for Routine IGF-1 Screening in Poorly Controlled Type 2 Diabetes Mellitus

    Endocrinology, Diabetes & Metabolism, 2026

    DOI 10.1002/edm2.70194 PMID 41878803 Texte intégral en libre accèsSource : ORCID

  9. Adrenal Rest Tumors and the clinical course of gonadal dysfunction in adult men with Congenital Adrenal Hyperplasia caused by 21-Hydroxylase Deficiency: A single-center experience with long-term follow-up

    Endocrine, 2026

    DOI 10.1007/s12020-026-04801-6 PMID 42804041 Source : Europe PMC

  10. Short-Term Real-World Clinical Outcomes of the Fixed-Ratio Combination of Insulin Glargine and Lixisenatide in Type 2 Diabetes

    Gazi Medical Journal, 2026

    DOI 10.12996/gmj.2026.4631 Texte intégral en libre accèsSource : OpenAlex

  11. NE07 A simple clinical and biochemical prediction score for distinguishing ectopic ACTH syndrome from Cushing disease

    European Journal of Endocrinology, 2026

    DOI 10.1093/ejendo/lvag128.051 Texte intégral en libre accèsSource : OpenAlex

  12. EP1457 - ECE_3005 - Factors associated with recurrence and persistent disease in subacute thyroiditis—a retrospective observational study of 370 patients

    European Journal of Endocrinology, 2026

    DOI 10.1093/ejendo/lvag096.1637 Texte intégral en libre accèsSource : OpenAlex

  13. EP1745 - LBA_ECE_1299 - An unusual presentation: panhypopituitarism and central diabetes insipidus revealing small cell lung cancer

    European Journal of Endocrinology, 2026

    DOI 10.1093/ejendo/lvag096.1801 Texte intégral en libre accèsSource : OpenAlex

  14. Thyroid carcinoma in Graves’ disease: a retrospective analysis of prevalence, histological subtypes, and clinical predictors

    BMC Endocrine Disorders, 2026

    DOI 10.1186/s12902-026-02413-9 Texte intégral en libre accèsSource : OpenAlex

  15. Temporal Variation of Biochemical Markers and Adenoma Predictors in Normocalcemic Primary Hyperparathyroidism: A Multicenter Retrospective Analysis

    Clinical Endocrinology, 2025

    DOI 10.1111/cen.70024 PMID 40891177 2 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  16. DİYABET TANI ve TEDAVİ REHBERİ

    Ataturk University - AVESIS, 2025

    Source : OpenAlex

  17. Clinical characteristics of Graves' disease following COVID-19 infection or vaccination: a multicenter case-control study

    Turkish journal of medical sciences, 2025

    DOI 10.55730/1300-0144.6096 PMID 41509944 1 citation (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  18. Clinical characteristics, mid-term outcomes and management of asymptomatic primary hyperparathyroidism: A multicentre retrospective cohort study

    Endocrine, 2025

    DOI 10.1007/s12020-025-04380-y PMID 40790100 Texte intégral en libre accèsSource : OpenAlex

  19. An underdiagnosed manifestation: Mandibular bone loss in primary hyperparathyroidism

    Bone, 2025

    DOI 10.1016/j.bone.2025.117598 PMID 40769418 Source : ORCID

  20. Clinical outcomes and treatment adequacy assessment in congenital adrenal hyperplasia: A Single-Center experience with Long-Term Follow-Up

    Endocrine, 2025

    DOI 10.1007/s12020-025-04411-8 PMID 40903614 Source : ORCID

  21. Effects of vitamin D replacement combined with Graves' disease therapy: a retrospective cohort study

    Turkish Journal of Medical Sciences, 2025

    DOI 10.55730/1300-0144.5946 PMID 40104316 2 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  22. Good response rates and predictors during the first year of cabergoline treatment in large invasive prolactinomas

    Pituitary, 2025

    DOI 10.1007/s11102-025-01512-5 PMID 40064718 5 citations (Europe PMC) Source : ORCID

  23. Importance of Hypomagnesemia in Primary Hyperparathyroidism: A Turkish Nationwide Retrospective Cohort Study

    Biological Trace Element Research, 2025

    DOI 10.1007/s12011-024-04481-1 PMID 39666169 Source : ORCID

  24. Machine Learning Prediction of Pancreatitis Risk With Antithyroid Drugs: A Nationwide Retrospective Observational Study

    The Journal of Clinical Endocrinology & Metabolism, 2025

    DOI 10.1210/clinem/dgae628 PMID 39324654 Source : ORCID

  25. Ongoing discussion: Is prophylactic central neck dissection necessary in cT1a-b,2N0 papillary thyroid cancer?

    Tumori Journal, 2025

    DOI 10.1177/03008916251334884 PMID 40462273 2 citations (Europe PMC) Source : ORCID

  26. Serum selenium levels and subacute thyroiditis: associations with disease course and long-term outcomes in a case-control study

    BMC Endocrine Disorders, 2025

    DOI 10.1186/s12902-025-01903-6 PMID 40102831 Texte intégral en libre accèsSource : ORCID

  27. The impact of hypophosphatemia on biochemical profile and renal outcomes in primary hyperparathyroidism: a nationwide retrospective study

    Turkish Journal of Medical Sciences, 2025

    DOI 10.55730/1300-0144.6095 PMID 41509939 1 citation (Europe PMC) Texte intégral en libre accèsSource : ORCID

  28. Early prolactin normalization and tumor shrinkage predict the first-year response to cabergoline treatment in invasive macro-giant prolactinomas

    Endocrine Abstracts, 2025

    DOI 10.1530/endoabs.110.p933 Source : OpenAlex

  29. Pioglitazone/Exenatide/SGLT-2 inhibitor combination therapy versus insulin therapy in patients with poorly controlled type 2 diabetes

    Anatolian Current Medical Journal, 2024

    DOI 10.38053/acmj.1415215 Texte intégral en libre accèsSource : ORCID

  30. Disrupted harmony of the skull skeleton: Middle ear resonance in acromegaly

    Growth Hormone and IGF Research, 2024

    DOI 10.1016/j.ghir.2024.101594 PMID 38833815 1 citation (Europe PMC) Source : ORCID

  31. Electrocardiographic ventricular arrhythmia parameters during diagnosis and after the treatment of acromegaly: A case-control study

    Heliyon, 2024

    DOI 10.1016/j.heliyon.2024.e38033 PMID 39398067 3 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  32. Growth Differentiation Factor 15 in Patients with Acromegaly: A Case–Control Study

    Endocrinology Research and Practice, 2024

    DOI 10.5152/erp.2024.24424 Texte intégral en libre accèsSource : ORCID

  33. Hypomagnesemia may be associated with symptomatic disease in patients with primary hyperparathyroidism

    Endocrine, 2024

    DOI 10.1007/s12020-023-03577-3 PMID 37922091 9 citations (Europe PMC) Source : ORCID

  34. The prevalence and associated risk factors of detectable renal morphological abnormalities in acromegaly

    Pituitary, 2024

    DOI 10.1007/s11102-023-01370-z PMID 38064149 6 citations (Europe PMC) Source : ORCID

  35. O-07 Lipodystrophy: A disease to be considered in diabetes clinics

    JCEM Case Reports, 2024

    DOI 10.1210/jcemcr/luad146.024 Texte intégral en libre accèsSource : OpenAlex

  36. Growth differentiation factor 15 in patients with acromegaly: a case-control study

    Endocrine Abstracts, 2024

    DOI 10.1530/endoabs.99.ep351 Source : OpenAlex

  37. The impact of SGLT2-inhibitor therapy on platelet function in type 2 Diabetes mellitus

    Journal of Health Sciences and Medicine, 2023

    DOI 10.32322/jhsm.1202548 Texte intégral en libre accèsSource : ORCID

  38. Impact of 24-week dapagliflozin treatment on body weight, body composition, and cardiac risk indicators of patients with type-2 diabetes mellitus

    Turkish Journal of Medical Sciences, 2023

    DOI 10.55730/1300-0144.5683 PMID 38813008 1 citation (Europe PMC) Texte intégral en libre accèsSource : ORCID

  39. Metastatic diffuse follicular variant papillary thyroid cancer without cervical lymph node metastasis presenting with symptoms related to hypopituitarism

    Einstein (Sao Paulo, Brazil), 2023

    DOI 10.31744/einstein_journal/2023rc0229 PMID 37493833 Texte intégral en libre accèsSource : ORCID

  40. Real-time detection of acromegaly from facial images with artificial intelligence

    European Journal of Endocrinology, 2023

    DOI 10.1093/ejendo/lvad005 PMID 36747333 15 citations (Europe PMC) Source : ORCID

  41. The importance of hypophosphatemia in the clinical management of primary hyperparathyroidism

    Journal of Endocrinological Investigation, 2023

    DOI 10.1007/s40618-023-02064-w PMID 36929458 12 citations (Europe PMC) Source : ORCID

  42. Subacute THYROiditis Related to SARS-CoV-2 VAccine and Covid-19 (THYROVAC Study): A Multicenter Nationwide Study

    The Journal of clinical endocrinology and metabolism, 2023

    DOI 10.1210/clinem/dgad235 PMID 37186260 15 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  43. SARS-COV-2 Aşısı ve Covid-19 ile ilişkili subakut tiroiditler: Ulusal çok merkezli çalışma (THYROVAC ÇALIŞMASI)

    Kocaeli Üniversitesi - AVESİS, 2023

    Source : OpenAlex

  44. Effect of thyroid nodule size on cytology reliability and incidence of malignancy: A large cohort of 1205 patients from a single center

    Annales d'Endocrinologie, 2023

    DOI 10.1016/j.ando.2022.08.002 PMID 36126756 5 citations (Europe PMC) Source : ORCID

  45. Impact of the COVID-19 pandemic on the incidence, seasonal distribution, and characteristics of subacute thyroiditis

    Endocrine, 2023

    DOI 10.1007/s12020-022-03197-3 PMID 36129593 10 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  46. Prevalence and associated risk factors of simple renal cysts in primary hyperparathyroidism

    Hormones, 2023

    DOI 10.1007/s42000-022-00416-4 PMID 36319934 5 citations (Europe PMC) Source : ORCID

  47. Prevalence and related risk factors of simple renal cysts and nephrolithiasis in acromegaly

    Endocrine Abstracts, 2023

    DOI 10.1530/endoabs.90.p441 Source : OpenAlex

  48. SARS-COV-2 AŞISI VE COVİD-19 İLE İLİŞKİLİ SUBAKUT TROİDİTLER: ULUSAL ÇOK MERKEZLİ ÇALIŞMA (THYROVAC ÇALIŞMASI)

    AYBU AVESIS, 2023

    Source : OpenAlex

  49. Cushing’s syndrome due to adrenocorticotropic hormone-secreting metastatic neuroendocrine tumor of unknown primary origin: a case report and literature review

    Hormones, 2022

    DOI 10.1007/s42000-021-00316-z PMID 34478059 11 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  50. Efficacy of cabergoline add-on therapy in patients with acromegaly resistance to somatostatin analogs treatment and the review of literature

    Archives of Endocrinology and Metabolism, 2022

    DOI 10.20945/2359-3997000000481 PMID 35612842 10 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID